Light Chain Bioscience (Switzerland)

Light Chain Bioscience (Switzerland)

Novimmune is a privately held Swiss pharmaceutical development company focusing on monoclonal antibody therapies for treatment of immune-related diseases. The company was founded in 1998. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Light Chain Bioscience (Switzerland), Switzerland, covering academic research published from 2002 to 2025. Read More.


Open Access Percentage

64%


Total
Publications

325


Total Open
Publications

209


Total
Citations

17K


Open Access
Percentage

64%


Total
Publications

325


Total Open
Publications

209


Total
Citations

17K

Wikipedia

Website

download

Breakdown

20% 38% 6% 36%

Publisher Open

20%

Both

38%

Other Platform Open

6%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820222426Total Publications
200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

54%OA Journal

OA Journal 54%

103

Hybrid 13%

24

No Guarantees 33%

64

Other Platform Open

Domain 81%

116

Institution 56%

80

Other Internet 16%

23

Preprint 5%

7

Public 5%

7

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
120
doaj.org OAI-PMH Repository
Institution
41
DOI
Other Internet
21
University of Geneva
Institution
16
University of Zurich
Institution
15
ETH Zurich
Institution
10
Figshare
Public
6
bioRxiv
Preprint
6
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
5
Europe PMC
Domain
5
1 / 6

Data updated 12 August 2026

Share

Share

Share